Pharmaceuticals

Pimozide Tablet Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Pimozide Tablet Market Expected To Scale Between 2026 And 2030?

The market for pimozide tablets has shown robust expansion in recent years. It is projected to increase from $1.84 billion in 2025 to $2.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The drivers behind its past growth include the limited therapeutic alternatives for Tourette’s syndrome, the increasing incidence of chronic schizophrenia, improvements in hospital and clinic infrastructure, heightened awareness of antipsychotic treatments, and a continued reliance on conventional offline pharmacies.

The pimozide tablet market is anticipated to experience robust expansion over the coming years, with projections indicating it will reach a value of $2.91 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This projected increase can be ascribed to several factors, including the creation of low-dose and unit-dose pimozide tablets, the proliferation of online pharmacy platforms, a rise in the adoption of home healthcare, growing government efforts in mental health, and the incorporation of digital tools for adherence monitoring. Key developments expected during this period encompass a greater understanding of Tourette’s syndrome and chronic schizophrenia, a growing inclination towards oral antipsychotic medications, an increase in mental health care and therapy delivered at home, the broadening of online channels for pharmaceutical distribution, and the emergence of tailored dosing and packaging solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19655&type=smp

Which Major Drivers Are Influencing The Expansion Of The Pimozide Tablet Market?

The expanding occurrence of psychiatric conditions is projected to boost the growth of the pimozide tablet market. Psychiatric disorders are mental health issues marked by significant disturbances in thoughts, feelings, or behaviors, leading to distress or impaired functioning. The rising prevalence of psychiatric disorders is largely due to factors such as elevated stress levels, shifting societal norms, enhanced awareness and diagnosis, and genetic predispositions. Pimozide tablets are used in psychiatric disorders to manage symptoms like delusions and tics by blocking dopamine receptors, thereby helping to reduce abnormal brain activity. For instance, in August 2025, data from the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based federal agency, showed that 23.4% of adults aged 18 or older (approximately 61.5 million people) experienced any mental illness (AMI), with about 5.6 % reporting a serious mental illness (SMI). In comparison, in 2023, 22.8 % (58.7 million people) and 5.7 % (14.6 million people) of adults reported AMI and SMI, respectively. Therefore, the increasing prevalence of psychiatric disorders is a key driver for the pimozide tablet market.

What Are The Main Segments Within The Pimozide Tablet Market Segment Structure?

The pimozide tablet market covered in this report is segmented –

1) By Type: 1 Milligram, 2 Milligram, 4 Milligram

2) By Distribution Channel: Online, Offline

3) By Application: Tourette’s Syndrome, Chronic Schizophrenia

4) By End User: Hospitals, Clinics, Home Use

Which Trends Are Contributing To Changes In The Pimozide Tablet Market?

Who Are The Companies Participating In The Pimozide Tablet Market?

Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals

Get The Full Pimozide Tablet Market Report:

https://www.thebusinessresearchcompany.com/report/pimozide-tablet-global-market-report

Which Geographic Region Dominates The Pimozide Tablet Market?

North America was the largest region in the pimozide tablet market in 2025. The regions covered in the pimozide tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pimozide Tablet Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pimozide-tablet-global-market-report

Browse Through More Reports Similar to the Global Pimozide Tablet Market 2026, By The Business Research Company

Smart Phone Tablet Games Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-phone-tablet-games-global-market-report

Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Multivitamin Capsules And Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/multivitamin-capsules-and-tablets-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795